Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma

被引:44
作者
Baldi, A
Santini, D
Battista, T
Dragonetti, E
Ferranti, G
Petitti, T
Groeger, AM
Angelini, A
Rossiello, R
Baldi, F
Natali, PG
Paggi, MG
机构
[1] Regina Elena Inst Canc Res, Ctr Expt Res, Lab Cell Metab & Pharmacokinet, I-00158 Rome, Italy
[2] Campus Biomed Univ, Rome, Italy
[3] Ctr Diagnost, Rome, Italy
[4] IDI, Serv Histopathol, Rome, Italy
[5] Univ Vienna, Dept Cardiothorac Surg, A-1010 Vienna, Austria
[6] Univ Naples 2, Dept Biochem & Biophys F Cedrangolo, Sect Pathol, Naples, Italy
[7] Regina Elena Inst Canc Res, Ctr Expt Res, Immunol Lab, I-00161 Rome, Italy
关键词
human skin melanoma; AP-2; p21; c-kit; E-cadherin; immunohistochemistry;
D O I
10.1002/jcb.1235
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The AP-2 transcription factor plays a pivotal role in regulating the expression of several genes involved in tumor growth and progression of melanoma. We determined, by Western blot, variation in the level of expression of AP- and three of its downstream targets, c-kit, E-cadherin, and p21 in several human melanoma cell lines and, by immunohistochemistry, in a group of 99 histological samples including benign and malignant melanocytic lesions. A significant negative correlation between AP-2 expression level and tumor thickness was found. Moreover, AP-2 expression was positively associated with E-cadherin and c-kit expression. In contrast, there was a significant negative association between AP-2 and p21 expression levels. These findings suggest that p21 is independent of AP-2 transactivator function during the latest phases of melanoma progression. Finally, AP-2, c-kit, E-cadherin, and p21 expression levels did not show to be able to distinguish between dysplastic nevi and nevi without dysplasia. We conclude that changes in the expression of these proteins are involved in the later phases of melanoma progression, and may be responsible for the transition from local invasive melanoma to metastasis. J. Cell. Biochem. 83: 364-372, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:364 / 372
页数:9
相关论文
共 33 条
  • [11] Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO
  • [12] 2-W
  • [13] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [14] LOCALIZATION OF THE GENE FOR THE DNA-BINDING PROTEIN AP-2 TO HUMAN-CHROMOSOME 6P22.3-PTER
    GAYNOR, RB
    MUCHARDT, C
    XIA, Y
    KLISAK, I
    MOHANDAS, T
    SPARKES, RS
    LUSIS, AJ
    [J]. GENOMICS, 1991, 10 (04) : 1100 - 1102
  • [15] Mechanisms identified in the transcriptional control of epithelial gene expression
    Hennig, G
    Lowrick, O
    Birchmeier, W
    Behrens, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) : 595 - 602
  • [16] Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
    Huang, S
    Jean, D
    Luca, M
    Tainsky, MA
    Bar-Eli, M
    [J]. EMBO JOURNAL, 1998, 17 (15) : 4358 - 4369
  • [17] Huang SY, 1996, ONCOGENE, V13, P2339
  • [18] TRANSCRIPTION FACTOR AP-2 MEDIATES INDUCTION BY 2 DIFFERENT SIGNAL-TRANSDUCTION PATHWAYS - PROTEIN-KINASE-C AND CAMP
    IMAGAWA, M
    CHIU, R
    KARIN, M
    [J]. CELL, 1987, 51 (02) : 251 - 260
  • [19] Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma
    Karjalainen, JM
    Kellokoski, JK
    Eskelinen, MJ
    Alhava, EM
    Kosma, VM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3584 - 3591
  • [20] LASSAM N, 1992, ONCOGENE, V7, P51